Adial Pharmaceuticals (ADIL) Interest Coverage Ratio (2017 - 2025)
Adial Pharmaceuticals (ADIL) posted Interest Coverage Ratio of 22.96 for Q1 2025, down 207.98% sequentially from 7.46 in Q4 2024, and up 93.69% YoY from 11.86 in Q1 2024.
Adial Pharmaceuticals (ADIL) Interest Coverage Ratio (2017 - 2025) Analysis & Trends
Adial Pharmaceuticals has reported Interest Coverage Ratio for 9 years, with the latest figure at 22.96 in Q1 2025.
- Quarterly Interest Coverage Ratio rose 93.69% year-over-year to 22.96 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 35.97 (down 6.97% YoY) and the FY2025 annual result came in at 0.47, up 12.53% from the prior year.
- Interest Coverage Ratio slipped to 22.96 in Q1 2025 per ADIL's latest filing, from 7.46 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.64 in Q3 2021 and troughed at 19803.28 in Q3 2022.
- A 5-year average of 1371.26 and a median of 25.72 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2022: Interest Coverage Ratio surged 99.81% in 2021, then sank 3102853.37% in 2022.
- Over 5 years, Interest Coverage Ratio stood at 264.97 in 2021, then soared by 93.52% to 17.16 in 2022, then jumped by 34.6% to 11.22 in 2023, then soared by 33.55% to 7.46 in 2024, then slumped by 207.98% to 22.96 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 22.96, 7.46, and 122.23 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Adial Pharmaceuticals | 26.99 Mn | 26.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -22.96 |
| Dec 31, 2024 | -7.46 |
| Sep 30, 2024 | -122.23 |
| Jun 30, 2024 | -282.35 |
| Mar 31, 2024 | -364.07 |
| Dec 31, 2023 | -11.22 |
| Jun 30, 2023 | -28.47 |
| Mar 31, 2023 | -162.06 |
| Dec 31, 2022 | -17.16 |
| Sep 30, 2022 | -19,803.28 |
| Jun 30, 2022 | -842.55 |
| Mar 31, 2022 | -4.28 |
| Dec 31, 2021 | -264.97 |
| Sep 30, 2021 | -0.64 |
| Jun 30, 2021 | -2.87 |
| Mar 31, 2021 | -3.62 |
| Dec 31, 2020 | -0.57 |
| Sep 30, 2020 | -3.18 |
| Jun 30, 2020 | -1,515.66 |
| Mar 31, 2020 | -221.43 |